Stryker
SYK348.0401.20% ( -4.210 )
Q1 FY2026 EarningsQ2 2026 revenue reached $6.6B, up 9.4% YoY with organic growth at 9.0%. MedSurg and Neurotechnology sales rose 9.7% to $3.6B, while Orthopaedics increased 9.1% to $3.0B. Reported operating margin expanded to 25.2%, and Adjusted operating margin rose 170bps to 27.4%. Diluted EPS surged 44.1% to $3.30 (Adjusted EPS at $3.69, +17.9%), reflecting a strong recovery from recent cybersecurity challenges.
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Stryker(SYK) predict that the Revenue is 6.02 B (+2.63%), Miss estimate;the EBIT is 1.271 B (-5.43%), Miss estimate;the EPS is 1.93 (+14.2%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
6.02B2.63%
6.33B7.90%
-0.31B5.27%
EBITMiss expectations
1.27B5.43%
1.47B9.42%
-0.20B14.85%
EPSMiss expectations
1.9314.20%
2.26834.20%
-0.338020.00%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateJul 30, 2026
Estimate Revenue6.579 B
Estimate EBIT1.699 B
Estimate EPS2.9653
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf